Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

The interview can be heard at

Organigram CEO Greg Engel, a 30-year veteran of the pharmaceuticals, biotech, consumer packed goods and cannabis sectors, joins NNW’s Stuart Smith in an interview that discusses the company’s dramatic growth within Canada and its strategic expansion on a global scale. As one of the original 15 Canadian cannabis companies focused on the medical cannabis space, Organigram has evolved to serve Canada’s adult recreational market and sees significant opportunity in the country’s upcoming legalization of edible and derivative products.

“We are only one of three companies that currently have distribution agreements in all 10 provinces in Canada,” Engel says, noting Organigram has taken a “measured approach” toward growth since its launch as a small, regional player in the western region of Canada.

The company recently uplisted to the Toronto Stock Exchange (TSX) from the TSX Venture Exchange (TSX.V) under the symbol “OGI,” a move that has generated considerable interest from traditional funds and large institutional investors, Engel says. Organigram’s Q3 and fiscal year-to-date results represent some of the strongest operating and financial metrics amongst Canadian licensed producers, placing it in the top tier of the Canadian industry.

Organigram’s focus on indoor, vertical cultivation methods allows the company to maximize its footprint, reduce operating costs and produce the highest quality products, Engel says. The company’s ability to meet its commitments has also been a large part of its success and reputation as a trusted supplier.

“One of the challenges for some companies is over-committing or over-promising on delivery, and that may have led to some practices that put them offside with regulators or from an operations perspective, or with their client base, their customers,” Engel says, adding good corporate governance practices and oversight of operations through a fully independent board of directors also sets Organigram apart from its competitors.

Engel concludes with a look at Organigram’s international expansion plans and a nod to Canada’s soon-to-be-open edibles and derivatives marketplace. The company’s disruptive nano-emulsion technology is being used to create a full range of derivative products including a tasteless, fast-acting and quick offset dissolvable powder for beverages, along with a selection of edibles, including chocolates produced by a team with extensive experience in the space.

Listen to the full interview here:

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.

Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at

About NetworkNewsAudio

NetworkNewsAudio (NNA) , a NetworkNewsWire (NNW) Solution, allows you to sit back and listen to market updates, CEO interviews and a Company AudioPressRelease (APR). These audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio (NNA) can assist your company by cutting through the overload of information in today’s market, NNA brings its clients unparalleled visibility, recognition and brand awareness. NetworkNewsWire (NNW) is where news, content and information converge. NetworkNewsWire (NNW) is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW has the unparalleled ability to reach a wide audience of investors, consumers, journalists and the general public with an ever-growing distribution network of more than 5,000 key syndication outlets across the nation.

For more information, visit:

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications:

NetworkWire (NW)
New York, New York
212.418.1217 Office
[email protected]

Should you invest in Organigram? See our technical and fundamental analysis reporting to determine if Organigram is a strong cannabis investment.

Organigram Holdings Inc. CEO Discusses Rampant Growth

About Cannin: Your Marijuana Stock Experts

Cannin is your #1 trusted resource for marijuana and hemp stock investment opportunities. Our global team of experts evaluates all emerging marijuana and hemp stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana and hemp stock investments for 2020. 

Use Cannin as your resource for:

Is it too late to invest in marijuana or hemp stocks? No! This is the perfect time to invest.

Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana and hemp stocks is now. Are you looking to buy stock in hemp companies or marijuana companies for 2020? Interested in emerging penny hemp stock companies? Looking for the best Canadian marijuana stocks to invest in? We can help.

Predict price movements of marijuana and hemp stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +25% Gains in 2020
  • +49.8% Gains in 2019
  • Backtested since 2012

We’re so confident you’ll love our signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best marijuana stocks – we’ll show you how at

Can we start writing exclusively about Hemp-Only companies? These include the following: Charlotte’s Web, GW Pharma, CV Sciences, Canopy Growth, Elixinol, Organigram, GrowLife, Emerald Health, Neptune, Global Hemp Group. Also, please see the attached report with additional hemp only companies with analysis. It’s from last year so the data is not current but worth a look.

Hemp Stocks, Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading